PD-1 and PD-L1 expression in pulmonary carcinoid tumors and their association to tumor spread
Vesterinen, T., Kuopio, T., Ahtiainen, M., Knuuttila, A., Mustonen, H., Salmenkivi, K., Arola, J., & Haglund, C. (2019). PD-1 and PD-L1 expression in pulmonary carcinoid tumors and their association to tumor spread. Endocrine Connections, 8(9), 1168-1175. https://doi.org/10.1530/EC-19-0308
Julkaistu sarjassaEndocrine Connections
© 2019 The authors. Published by Bioscientifica Ltd
Pulmonary carcinoid (PC) tumors are rare tumors that account for approximately 1% of all lung cancers. The primary treatment option is surgery, while there is no standard treatment for metastatic disease. As the number of PCs diagnosed yearly is increasing, there is a need to establish novel therapeutic options. This study aimed to investigate programmed death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) expression in PC tumors since blocking of the PD-1/PD-L1 pathway is a promising therapeutic option in various other malignancies. A total of 168 PC patients treated between 1990 and 2013 were collected from the Finnish biobanks. After re-evaluation of the tumors, 131 (78%) were classified as typical carcinoid (TC) and 37 (22%) as atypical carcinoid (AC) tumors. Primary tumor samples were immunohistochemically labeled for PD-1, PD-L1 and CD8. High PD-1 expression was detected in 16% of the tumors. PD-L1 expression was detected in 7% of TC tumors; all AC tumors were PD-L1 negative. PD-L1 expression was associated with mediastinal lymph-node metastasis at the time of diagnosis (P = 0.021) as well as overall metastatic potential of the tumor (P = 0.010). Neither PD-1 expression, PD-L1 expression nor CD8+ T cell density was associated with survival. In conclusion, PD-1 and PD-L1 were expressed in a small proportion of PC tumors and PD-L1 expression was associated with metastatic disease. Targeting of the PD-1/PD-L1 pathway with immune checkpoint inhibitors may thus offer a treatment option for a subset of PC patients. ...
MetadataNäytä kaikki kuvailutiedot
Lisätietoja rahoituksestaThis work was supported by the Finnish Cancer Foundation (no grant number) and the Helsinki University Hospital Research Fund (grant number TYH2017204).
Näytetään aineistoja, joilla on samankaltainen nimeke tai asiasanat.
Variants associated with HHIP expression have sex-differential effects on lung function [version 1; peer review: 2 approved] Fawcett, KA; Obeidat, M; Melbourne, C; Shrine, N; Guyatt, AL; John, C; Luan, J; Richmond, A; Moksnes, MR; Granell, R; Weiss, S; Imboden, M; May-Wilson, S; Hysi, P; Boutin, TS; Portas, L; Flexeder, C; Harris, SE; Wang, CA; Lyytikäinen, LP; Palviainen, T; Foong, RE; Keidel, D; Minelli, C; Langenberg, C; Bossé, Y; Van den Berge, M; Sin, DD; Hao, K; Campbell, A; Porteous, D; Padmanabhan, S; Smith, BH; Evans, DM; Ring, S; Langhammer, A; Hveem, K; Willer, C; Ewert, R; Stubbe, B; Pirastu, N; Klaric, L; Joshi, PK; Patasova, K; Massimo, M; Polasek, O; Starr, JM; Karrasch, S; Strauch, K; Meitinger, T; Rudan, I; Rantanen, T.; Pietiläinen, K; Kähönen, M; Raitakari, OT; Hall, GL; Sly, PD; Pennell, CE; Kaprio, J; Lehtimäki, T; Vitart, V; Deary, IJ; Jarvis, D; Wilson, JF; Spector, T; Probst-Hensch, N; Wareham, NJ; Völzke, H; Henderson, J; Strachan, DP; Brumpton, BM; Hayward, C; Hall, IP; Tobin, MD; Wain, LV (Wellcome Trust, 2020)Background: Lung function is highly heritable and differs between the sexes throughout life. However, little is known about sex-differential genetic effects on lung function. We aimed to conduct the first genome-wide ...
Predictive value of p53, Ki67 and TLR5 in neoplastic progression of Barrett’s esophagus : a matched case-control study Helminen, Olli; Melkko, Jukka; Saarnio, Juha; Sihvo, Eero; Kuopio, Teijo; Ohtonen, Pasi; Kauppila, Joonas H.; Karttunen, Tuomo J.; Huhta, Heikki (Springer, 2022)Barrett’s esophagus progresses to high-grade dysplasia or cancer along the well-established metaplasia-dysplasia-adenocarcinoma sequence. The aim of this study was to evaluate the value of p53, Ki67, and toll-like receptor ...
Vesterinen, Tiina; Salmenkivi, Kaisa; Mustonen, Harri; Kuopio, Teijo; Lappi-Blanco, Elisa; Paavonen, Timo; Vainio, Paula; Knuuttila, Aija; Carpén, Olli; Haglund, Caj; Arola, Johanna (Springer, 2020)Finnish hospital-integrated biobanks administer millions of formalin-fixed paraffin-embedded tissue samples collected within the clinical diagnostics. According to the Finnish Biobank Act, these samples can be coupled with ...